Description
Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus
€2.42
Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus
Reviews
There are no reviews yet.